Centiva Capital, LP Biogen Inc. Put Options Transaction History

Centiva Capital, LP

$3.72 Billion
Q1 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.55 Million - $1.74 Million	6,100 New	6,100 $1.57 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $631,100 - $766,800	-2,500 Reduced 42.37%	3,400 $941,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4.59 Million - $6.34 Million	-23,600 Reduced 80.0%	5,900 $1.58 Million
Q2 2022 Aug 17, 2022	SELL	$187.54 - $223.02 $4.26 Million - $5.06 Million	-22,700 Reduced 43.49%	29,500 $6.02 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $5.58 Million - $7.03 Million	28,800 Added 123.08%	52,200 $11 Million

Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $5.24 Million - $6.73 Million	23,400 New	23,400 $5.61 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.12 Million - $1.31 Million	-4,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $310,392 - $411,060	1,200 Added 35.29%	4,600 $1.23 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $6.88 Million - $8.73 Million	-25,600 Reduced 88.28%	3,400 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $2.18 Million - $3.01 Million	9,900 Added 51.83%	29,000 $8.6 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $3.5 Million - $3.93 Million	16,100 Added 536.67%	19,100 $4.45 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $614,012 - $676,816	-2,800 Reduced 48.28%	3,000 $701,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $86,684 - $135,584	-400 Reduced 6.45%	5,800 $1.37 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $807,650 - $1.02 Million	2,900 Added 87.88%	6,200 $1.87 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $849,815 - $1.01 Million	3,300 New	3,300 $957,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.72 Billion
0.07% of portfolio
Primecap Management CO Pasadena, CA

16.2M
Shares

$3.64 Billion
2.65% of portfolio
Black Rock Inc. New York, NY

14.1M
Shares

$3.18 Billion
0.07% of portfolio
State Street Corp Boston, MA

6.75M
Shares

$1.52 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.17M
Shares

$1.16 Billion
0.68% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account